Evolva Holding (Evolva Holding) Days Sales Outstanding : 129.77 (As of Jun. 2023)

View and export this data going back to 2006. Start your Free Trial

What is Evolva Holding Days Sales Outstanding?

Evolva Holding's average Accounts Receivable for the six months ended in Jun. 2023 was $3.52 Mil. Evolva Holding's Revenue for the six months ended in Jun. 2023 was $4.95 Mil. Hence, Evolva Holding's Days Sales Outstanding for the six months ended in Jun. 2023 was 129.77.

The historical rank and industry rank for Evolva Holding's Days Sales Outstanding or its related term are showing as below:

ELVAF' s Days Sales Outstanding Range Over the Past 10 Years
Min: 13.81 Med: 71.89 Max: 120.9
Current: 120.9

During the past 13 years, Evolva Holding's highest Days Sales Outstanding was 120.90. The lowest was 13.81. And the median was 71.89.

ELVAF's Days Sales Outstanding is ranked worse than
73.54% of 892 companies
in the Biotechnology industry
Industry Median: 72.19 vs ELVAF: 120.90

Evolva Holding's Days Sales Outstanding increased from Jun. 2022 (91.85) to Jun. 2023 (129.77).

Evolva Holding Days Sales Outstanding Historical Data

The historical data trend for Evolva Holding's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Evolva Holding Days Sales Outstanding Chart

Evolva Holding Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Days Sales Outstanding

Get a 7-Day Free Trial

59.74

44.91

72.20

85.25

72.26

Evolva Holding Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Days Sales Outstanding	Get a 7-Day Free Trial															92.13	191.09	91.85	105.20	129.77

Competitive Comparison of Evolva Holding's Days Sales Outstanding

For the Biotechnology subindustry, Evolva Holding's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Evolva Holding's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Evolva Holding's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Evolva Holding's Days Sales Outstanding falls into.

Evolva Holding Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Evolva Holding's Days Sales Outstanding for the fiscal year that ended in Dec. 2022 is calculated as

	Days Sales Outstanding (A: Dec. 2022 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2021 )	+	Accounts Receivable (A: Dec. 2022 ))	/	count )	/	Revenue (A: Dec. 2022 )	*	Days in Period
=	( (2.94	+	3.664)	/	2 )	/	16.68	*	365
=	3.302					/	16.68	*	365
=	72.26

Evolva Holding's Days Sales Outstanding for the quarter that ended in Jun. 2023 is calculated as:

	Days Sales Outstanding (Q: Jun. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Jun. 2023 ))	/	count )	/	Revenue (A: Jun. 2023 )	*	Days in Period
=	( (3.664	+	3.37)	/	2 )	/	4.946	*	365 / 2
=	3.517					/	4.946	*	365 / 2
=	129.77

Evolva Holding (OTCPK:ELVAF) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Evolva Holding Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Evolva Holding's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Evolva Holding (Evolva Holding) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Evolva Holding SA (OTCPK:ELVAF) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

EVEz:UK EVE:Switzerland

Address

Duggingerstrasse 23, Reinach, CHE, CH-4153

Website

https://www.evolva.com

Evolva Holding SA en liquidation formerly Evolva Holding SA is a biotechnology company. The company is engaged in discovering, developing, and commercializing ingredients and biomanufacturing processes for nutrition, healthcare, and wellness products. Geographically, the company operates in Switzerland and the United States where Switzerland derives a majority of its revenue.

Evolva Holding (Evolva Holding) Headlines

From GuruFocus

Half Year 2023 Evolva Holding SA Earnings Call Transcript

By GuruFocus Research • 02-13-2024